Genocea Biosciences

YTD

ALL

Why Robinhood?

You can watch GNCA and buy or sell other stocks, ETFs, and their options commission-free!

About GNCA

Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses.

CEO

Chip Clark, MBA

CEOChip Clark, MBA

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2006

Founded2006

Employees

—

Employees—

GNCA Key Statistics

Market cap

5.90K

Market cap5.90K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.28K

Average volume1.28K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.0001

52 Week high$0.0001

52 Week low

—

52 Week low—

Stock Snapshot

The current Genocea Biosciences(GNCA) stock price is $2.26, with a market capitalization of 5.9K.

On 2026-02-15, Genocea Biosciences(GNCA) stock opened at —, reached a high of —, and a low of —.

Genocea Biosciences(GNCA) shares are trading with a volume of 0, against a daily average of 1.28K.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.